Skip to main content
SpringerLink
Log in

Hypertension

Current Therapeutic Practice Reviewed

  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Andrews G, MacMahon SW, Austin A, Byrne DG. Hypertension: comparison of drug and non-drug treatments. British Medical Journal 284: 1523–1526, 1982

    Article  PubMed  CAS  Google Scholar 

  • Australian Therapeutic Trial in Mild Hypertension. Report by the Management Committee. Lancet 1: 1261–1267, 1980

    Google Scholar 

  • BHAT (β-Blocker Heart Attack Trial Research Group). 1. Mortality results 1982. A randomized trial of propranolol in patients with acute myocardial infarction. Journal of the American Medical Association 247: 1707–1714, 1982

    Article  Google Scholar 

  • Beard TC, Gray WR, Cooke HM, Barge R. Randomised controlled trial of a no-added-sodium diet for mild hypertension. Lancet 2: 455–458, 1982

    Article  PubMed  CAS  Google Scholar 

  • Bendall MJ, Baloch KH, Wilson PR. Side effects due to treatment of hypertension with prazosin. British Medical Journal 2: 727–728, 1975

    Article  PubMed  CAS  Google Scholar 

  • Bertel O, Conen D, Radu EW, et al. Nifedipine in hypertensive emergencies. British Medical Journal 286: 19–22, 1983

    Article  PubMed  CAS  Google Scholar 

  • Boyer JL, Kasch FW. Exercise therapy in hypertensive men. Journal of the American Medical Association 211: 1668–1671, 1970

    Article  PubMed  CAS  Google Scholar 

  • Buhler FR, Bolli P, Erne P, et al. Position of calcium antagonists in antihypertensive therapy. Journal of Cardiovascular Pharmacology 7 (Suppl. 4): S21–S27, 1985

    Article  PubMed  Google Scholar 

  • Case DB, Atlas SA, Mouradian JA, et al. Proteinuria during long-term captopril therapy. Journal of the American Medical Association 244: 346–349, 1980

    Article  PubMed  CAS  Google Scholar 

  • Dombey S. Optimal dose of captopril in hypertension. Lancet 1: 529, 1983

    Article  PubMed  CAS  Google Scholar 

  • Graham RM. Selective alpha1adrenergic antagonists: therapeutically relevent antihypertensive agents. American Journal of Cardiology 53: 16A-20A, 1984

    Article  CAS  Google Scholar 

  • Havard CWH, Khokhar AM, Flax JS. Open assessment of the effect of prazosin on plasma lipids. Journal of Cardiovascular Pharmacology 14 (Suppl. 2): S238–S241, 1982

    Google Scholar 

  • Hodsman GP, Isles CG, Murray GD, et al. Factors related to first dose hypotensive effect of captopril: prediction and treatment. British Medical Journal 286: 832–834, 1983

    Article  PubMed  CAS  Google Scholar 

  • HDFP (Hypertensive Detection and Follow-up Programme Cooperation Group). Five-year findings of the Hypertension Detection and Follow-up Program. 1. Reduction in mortality of persons with high blood pressure, including mild hypertension. Journal of the American Medical Association 242: 2562–2577, 1979

    Article  Google Scholar 

  • Johnston CI. Angiotensin converting enzyme inhibitors. In Doule (Ed.) Handbook of hypertension, Vol. 5, Clinical pharmacology of antihypertensive drugs, pp. 272–311, Elsevier Science Publishers BV, Amsterdam, 1984

    Google Scholar 

  • Kokubu T, Itoh I, Kurita H, et al. Effect of prazosin on serum lipids. Journal of Cardiovascular Pharmacology 14 (Suppl. 2): S228–S232, 1982

    Article  Google Scholar 

  • Krebs R. Adverse reactions with calcium antagonists. Hypertension 5 (Suppl. 2): 125–129, 1983

    Google Scholar 

  • Lant A. Diuretics: clinical pharmacology and therapeutic use. Drugs 29: 57–87 (Part I), 162–188 (Part II), 1985

    Article  PubMed  CAS  Google Scholar 

  • Lehmann JW, Benson H. The nonpharmacologic treatment of hypertension. In Genest et al. (Eds) Hypertension, 2nd ed., pp. 1238–1245, McGraw-Hill Book Company, New York, 1983

    Google Scholar 

  • Leren P, Eide I, Foss OP, et al. Antihypertensive drugs and blood lipids: the Oslo study. Journal of Cardiovascular Pharmacology 4 (Suppl. 2): S222–S224, 1982

    PubMed  Google Scholar 

  • MacGregor GA, Best FE, Cam JM, et al. Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet 1: 351–355, 1982

    Article  PubMed  CAS  Google Scholar 

  • MacGregor GA, Banks RA, Markandu ND, et al. Lack of effect of beta-blocker on flat dose response to thiazide in hypertension: Efficacy of low dose thiazide combined with beta-blocker. British Medical Journal 286: 1535–1538, 1983

    Article  PubMed  CAS  Google Scholar 

  • Morgan T, Gillies A, Morgan G, et al. Hypertension treated by salt restriction. Lancet 1: 227–230, 1978

    Article  PubMed  CAS  Google Scholar 

  • Norwegian Multicentre Study Group. Timolol-induced reduction in mortality and re-infarction in patients surviving acute myocardial infarction. New England Journal of Medicine 304: 801–807, 1981

    Article  Google Scholar 

  • Patel C, Marmot MG, Terry DJ. Controlled trial of biofeedbackaided behavioural methods in reducing mild hypertension. British Medical Journal 282: 2005–2008, 1981

    Article  PubMed  CAS  Google Scholar 

  • Prichard BNC, Owens CWI. Drug treatment of Hypertension. In Genest et al. (Eds) Hypertension, 2nd Ed., pp. 1171–1210, McGraw-Hill Book Company, New York, 1983

    Google Scholar 

  • Prichard BNC, Owens CWI. Clinical pharmacology of beta-adrenoceptor blocking drugs. In Kostis and De Felice (Eds) Beta blockers in the treatment of cardiovascular disease, pp 1–56, Raven Press, New York, 1984

    Google Scholar 

  • Puska P, Nissenen A, Vartiainen E, et al. Controlled, randomised trial of the effect of dietary fat on blood pressure. Lancet 1:1–5, 1983

    Article  PubMed  CAS  Google Scholar 

  • Reisen E, Abel R, Modan M, et al. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. New England Journal of Medicine 298(1): 1–6, 1978

    Article  Google Scholar 

  • Rosendorff C. Prazosin: severe side effects are dose-dependant. British Medical Journal 2: 508, 1976

    Article  PubMed  CAS  Google Scholar 

  • Sannerstedt R, Wasir H, Henning R, et al. Systemic haemodynamics in mild arterial hypertension before and after physical training. Clinical Science and Molecular Medicine 45: 145s–149s, 1973

    Google Scholar 

  • Seideman P, Grahnen A, Haglund K, et al. Prazosin first dose phenomenon during combined treatment with a β-adrenoceptor blocker in hypertensive patients. British Journal of Clinical Pharmacology 13: 865–870, 1982

    Article  PubMed  CAS  Google Scholar 

  • Stanaszek WF, Kellerman D, Brogden RN, et al. Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure. Drugs 25: 339–384, 1983

    Article  PubMed  CAS  Google Scholar 

  • Staessen J, Fagard R, Lijnen P, et al. Captopril and agranulocytosis. Lancet 1: 926, 1980

    Article  PubMed  CAS  Google Scholar 

  • Stokes GS, Graham RM, Gain JM, et al. Influence of dosage and dietary sodium on the first-dose effects of prazosin. British Medical Journal 1: 1507–1508, 1977

    Article  PubMed  CAS  Google Scholar 

  • Taylor SH. Alpha-adrenoceptor antagonists in hypertension. In Amery (Ed.) Hypertensive cardiovascular disease: pathophysiology and treatment, pp. 755–782, Martinus Nijhoff Publishers, The Hague, 1982

    Chapter  Google Scholar 

  • Tuck ML, Sowers J, Dornfeld L, et al. The effect of weight reduction on blood pressure, plasma renin activity and plasma aldosterone levels in obese patients. New England Journal of Medicine 304: 930–933, 1981

    Article  PubMed  CAS  Google Scholar 

  • Velasco M, Silva H, Morillo J, et al. Effect of prazosin on blood lipids and on thyroid function in hypertensive patients. Journal of Cardiovascular Pharmacology 4 (Suppl. 2): S225–S227, 1982

    PubMed  Google Scholar 

  • Veterans Administration Cooperative Study Group on Antihypertensive Agents. Racial differences in response to low dose captopril. British Journal of Clinical Pharmacology 14: 975, 1982

    Google Scholar 

  • Wasnich RD, Benfante RJ, Yano K, et al. Thiazide effect on the mineral content of bone. New England Journal of Medicine 309: 344–347, 1983

    Article  PubMed  CAS  Google Scholar 

  • Wilkin JK, Hammond JJ, Kirkendall WM. The captopril-induced eruption: dipeptidase inhibition and cutaneous kinin potentiation. Archives of Dermatology 116: 902–905, 1980

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, School of Medicine, University College, London, UK

    B. N. C. Prichard

Authors
  1. B. N. C. Prichard
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prichard, B.N.C. Hypertension. Drugs 31 (Suppl 1), 67–70 (1986). https://doi.org/10.2165/00003495-198600311-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198600311-00012

Keywords

Search

Navigation